KCC-TGX

N/A

Report date: 2025/10/23 17:53:49
NME

Base Information

Drug NameKCC-TGX
Drug Alias NameKCC-TGX
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsProstate-specific antigen modulatorsPI3-kinase class I inhibitors
TargetsEpidermal growth factor receptor erbB1Prostate-specific antigenPI3-kinase class I
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Missouri
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Missouri
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A